This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
US Biological
product type :
antibody
product name :
LILRA2, ID (LILRA2, ILT1, LIR7, Leukocyte immunoglobulin-like receptor subfamily A member 2, CD85 antigen-like family member H, Immunoglobulin-like transcript 1, Leukocyte immunoglobulin-like receptor 7, CD85h) (AP)
catalog :
037774-AP
quantity :
200 ul
clonality :
polyclonal
host :
domestic rabbit
conjugate :
AP
reactivity :
human
product information
Catalog Number :
037774-AP
Product wo Prefix :
LILRA2, ID (LILRA2, ILT1, LIR7, Leukocyte immunoglobulin-like receptor subfamily A member 2, CD85 antigen-like family member H, Immunoglobulin-like transcript 1, Leukocyte immunoglobulin-like receptor 7, CD85h) (AP)
Host :
rabbit
Product Type :
Pab
Conjugate :
AP
Category :
Antibodies
Size1 :
200 ul
Isotype :
IgG
Desc1 :
Leukocyte Ig-like receptors (LIRs) are a family of immunoreceptors expressed predominantly on monocytes and B cells and at lower levels on dendritic cells and natural killer (NK) cells. All LIRs in subfamily B have an inhibitory function (see, e.g., LILRB1, MIM 604811). LIRs in subfamily A, with short cytoplasmic domains lacking an immunoreceptor tyrosine-based inhibitory motif (ITIM) and with transmembrane regions containing a charged arginine residue, may initiate stimulatory cascades. One member of subfamily A (LILRA3; MIM 604818) lacks a transmembrane region and is presumed to be a soluble receptor.
Applications:
Suitable for use in Western Blot, ELISA
Recommended Dilution:
ELISA: 1:1,000
Western Blot: 1:100-500
1:10-50
Storage and Stability:
Store product at 4°C. DO NOT FREEZE! Stable at 4°C for 12 months after receipt as an undiluted liquid. Dilute required amount only prior to immediate use. Further dilutions can be made in assay buffer. For maximum recovery of product, centrifuge the original vial prior to removing the cap.
Note: Applications are based on unconjugated antibody.
Calc Crossreactivity :
Hu
Alternate Name :
LILRA2, ILT1, LIR7, Leukocyte immunoglobulin-like receptor subfamily A member 2, CD85 antigen-like family member H, Immunoglobulin-like transcript 1, Leukocyte immunoglobulin-like receptor 7, CD85h
Immunogen :
LILRA2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 62-89 amino acids from the Central region of human LILRA2.
Specificity :
Human
Purity :
Purified by Protein A affinity chromatography.
Form :
Supplied as a liquid in PBS, pH 7.2. No preservative added. Labeled with Alkaline Phophatase (AP).
Concentration :
As reported
Desc2 :
Product Type: Pab
Isotype: IgG
Host: rabbit
Source: human
Concentration: As reported
Form: Supplied as a liquid in PBS, pH 7.2. No preservative added. Labeled with Alkaline Phophatase (AP).
Purity: Purified by Protein A affinity chromatography.
Immunogen: LILRA2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 62-89 amino acids from the Central region of human LILRA2.
Specificity: Human
Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.
Calc Applications Abbrev :
E WB
Storage Temperature :
4°C Do Not Freeze
Reference :
Mosbruger, T.L., et al. J. Infect. Dis. 201(9):1371-1380(2010)
Davila, S., et al. Genes Immun. 11(3):232-238(2010)
Jones, D.C., et al. Eur. J. Immunol. 39(11):3195-3206(2009)
Chen, Y., et al. J. Mol. Biol. 386(3):841-853(2009)
Mamegano, K., et al. Genes Immun. 9(3):214-223(2008)
Picture 1 File Name :
https://usbio-images.r.worldssl.net/prodimages/27/037774-AP_1.jpg
company information
US Biological
4 Technology Way
Salem, MA01970
Salem, MA01970
service@usbio.net
https://www.usbio.net800-520-3011
headquarters: USA
United States Biological is a primary brand for the Life Science Industry. We are committed to reducing the cost of research with value, integrity and a truly personal buying experience.
questions and comments